Drug Information

Drug General Information
Drug ID
D0ZF8F
Former ID
DNCL002861
Drug Name
HIP-2B
Indication Type 1/2 diabetes [ICD9: 250, 278; ICD10:E08-E13] Phase 1 [524417]
Company
CureDM
Target and Pathway
Target(s) Human pro-islet peptide Target Info Modulator [525626]
References
Ref 524417ClinicalTrials.gov (NCT01933256) Study of Subcutaneous Doses of HIP2B in Subjects With Type 2 Diabetes Mellitus Treated With Metformin. U.S. National Institutes of Health.
Ref 525626Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells. Am J Pathol.1999 Nov;155(5):1525-33.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.